Psoriasis MRS 24-25
Male Female
< 5 years
5-10 years
11-20 years
>20 years
Multi-specialty hospital
Clinic/ nursing home
Government hospital/ medical college
Mixed
Tier 1 city
Tier 2 city
Tier 3 city
Rural area
< 5
5-10
10-15
15-20
>20
0-10
11-20
21-30
31-40
41-50
51-60
61-70
71-80
80-90
90-100
Clinical presentation
Skin biopsy
Blood investigations
Biomarker testing
Any other
PASI
BSA
PGA
DLQI
Psoriatic arthritis
Crohn's disease
Psychological/psychiatric disorders (DPP)
Uveitis
Metabolic syndrome
Topical steroids
Emollients
Topical steroids + Emollients
Phototherapy
Oral steroids
Vitamin D analogues
Biologicals
Methotrexate
Cyclosporine
Acitretin
Apremilast
Topical medication
Diarrhea
Headache
Nausea
Nasopharyngitis
1 week
2 week
3 weeks
1-2 weeks
> 2 weeks
Yes
No
BSA>20%
Not responding to conventional treatment
Frequent flares/unstable psoriasis
Cost
Tolerability
Efficacy
Long-term safety
Plaque-type
Guttate
Erythrodermic
Napkin-based
Nail-based